A detailed history of Ameritas Investment Partners, Inc. transactions in Quest Diagnostics Inc stock. As of the latest transaction made, Ameritas Investment Partners, Inc. holds 1,249 shares of DGX stock, worth $170,963. This represents 0.01% of its overall portfolio holdings.

Number of Shares
1,249
Previous 1,249 -0.0%
Holding current value
$170,963
Previous $172,000 3.49%
% of portfolio
0.01%
Previous 0.01%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 14, 2024

SELL
$120.62 - $141.12 $15,198 - $17,781
-126 Reduced 9.16%
1,249 $172,000
Q4 2022

Feb 13, 2023

SELL
$123.31 - $157.26 $17,633 - $22,488
-143 Reduced 9.42%
1,375 $215,000
Q1 2022

May 13, 2022

SELL
$129.09 - $164.35 $16,394 - $20,872
-127 Reduced 7.72%
1,518 $208,000
Q3 2021

Nov 15, 2021

SELL
$132.95 - $158.0 $26,855 - $31,916
-202 Reduced 10.94%
1,645 $239,000
Q1 2021

May 14, 2021

SELL
$114.63 - $133.34 $24,416 - $28,401
-213 Reduced 10.34%
1,847 $237,000
Q4 2020

Feb 12, 2021

SELL
$112.7 - $128.05 $10,481 - $11,908
-93 Reduced 4.32%
2,060 $245,000
Q2 2020

Aug 05, 2020

SELL
$73.34 - $122.61 $8,434 - $14,100
-115 Reduced 5.07%
2,153 $245,000
Q3 2019

Nov 14, 2019

SELL
$97.85 - $107.42 $14,090 - $15,468
-144 Reduced 5.97%
2,268 $243,000
Q4 2018

Feb 12, 2019

SELL
$79.75 - $108.38 $13,557 - $18,424
-170 Reduced 6.58%
2,412 $201,000
Q2 2018

Aug 13, 2018

SELL
$97.35 - $113.14 $23,071 - $26,814
-237 Reduced 8.41%
2,582 $284,000
Q1 2018

May 15, 2018

SELL
$96.42 - $107.88 $18,512 - $20,712
-192 Reduced 6.38%
2,819 $283,000
Q4 2017

Feb 14, 2018

SELL
$90.86 - $100.24 $13,810 - $15,236
-152 Reduced 4.81%
3,011 $297,000
Q2 2017

Aug 15, 2017

BUY
N/A
3,163
3,163 $352,000

Others Institutions Holding DGX

About QUEST DIAGNOSTICS INC


  • Ticker DGX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 113,887,000
  • Market Cap $15.6B
  • Description
  • Quest Diagnostics Incorporated provides diagnostic testing, information, and services in the United States and internationally. The company develops and delivers diagnostic information services, such as routine testing, non-routine and advanced clinical testing, anatomic pathology testing, and other diagnostic information services. It offers dia...
More about DGX
Track This Portfolio

Track Ameritas Investment Partners, Inc. Portfolio

Follow Ameritas Investment Partners, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ameritas Investment Partners, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Ameritas Investment Partners, Inc. with notifications on news.